But Khosla, the founder of Khosla Ventures, insists Two Pore Guys, which utilizes a technology called a nanopore to detect chemicals with high sensitivity, is the real deal. Heller doesn’t see Two Pore Guys developing its own diagnostic tests at all. Instead, it would form partnerships with existing diagnostic test makers (think Roche, Cepheid, or Abbott Laboratories) to port existing diagnostic tests on its machine. In the analogy favored by Heller and Khosla, the Two Pore Guys device is the iPhone and other companies would be app developers. Diagnostic test applications would come online several years later, as partners went through the process of getting approval from the FDA.

Source: Forbes April 25, 2017 11:26 UTC